Survivin 96-104 (HLA-A*02:01)
€57.50 *
Prices plus VAT plus shipping costs
Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
- Order number: EP11422_1
LMLGEFLKL is a linear peptidic epitope (epitope ID38060), tested in T cell assays. The vector of... more
Product information "Survivin 96-104 (HLA-A*02:01)"
LMLGEFLKL is a linear peptidic epitope (epitope ID38060), tested in T cell assays. The vector of anti-Survivin T cell receptor (TCR) is constructed for the engineering of T cell to target Human Survivin. The T cells are genetically modified through transduction with a retroviral vector expressing Survivin-specific T cell receptor. And the vector product was designed for the treatment of diseases involving malignant cells expressing survivin.
Available downloads:
####
| Sequence: | LMLGEFLKL | |
| Delivery: | 2-3 days | |
| C-Terminus: | OH | |
| N-Terminus: | H | |
| Purity: | 95% | |
| Amount: | 1 mg | |
| Counter Ion: | TFA | |
| Protein: | Survivin | |
| Species: | Human | |
| Allele: | HLA-A*02:01 | |
| Application : | Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry | |
| Indication : | AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1 |
Dokumente - Protokolle - Downloads more
Protocols and Tips
Data sheets
Viewed